D'Silva Andrew J. 4
4 · OptimizeRx Corp · Filed Dec 22, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
D'Silva Andrew J.
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-12-19$13.51/sh−703$9,498→ 44,735 total
Footnotes (1)
- [F1]These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.